Literature DB >> 949038

Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors.

J A Carney, G W Sizemore, S G Sheps.   

Abstract

Multiple endocrine neoplasia, type 2 (MEN-type 2), designates the syndrome of medullary thyroid carcinoma, pheochromocytoma, and occasional parathyroid hyperplasia. The thyroid carcinoma, which is usually bilateral and multicentric, is preceded by multifocal C-cell hyperplasia. The adrenal gland manifests pheochromocytoma, which is frequently bilateral and multicentric, and may be malignant. To test the hypothesis that diffuse adrenal medullary hyperplasia is a precursor of pheochromocytoma in this syndrome, we studied the adrenal glands of 19 patients who had MEN-type 2. The findings in the adrenal medulla in these 19 patients were: synchronous bilateral pheochromocytoma in 9 (metastatic in 3); asynchronous bilateral pheochromocytoma in 1 (metastatic); unilateral pheochromocytoma with contralateral diffuse and nodular hyperplasia in 2; unilateral pheochromocytoma with contralateral diffuse hyperplasia in 2; unilateral pheochromocytoma in 1; bilateral nodular hyperplasia in 1; bilateral diffuse hyperplasia in 1; and no abnormality in 2. This spectrum of adrenal medullary pathology suggests that diffuse and nodular medullary hyperplasia are precursors of pheochromocytoma in MEN-type 2.

Entities:  

Mesh:

Year:  1976        PMID: 949038     DOI: 10.1093/ajcp/66.2.279

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  37 in total

Review 1.  The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review.

Authors:  J B Hazard
Journal:  Am J Pathol       Date:  1977-07       Impact factor: 4.307

2.  Clonality of Endocrine Proliferative Lesions: A Critical Reappraisal.

Authors:  Ronald A. DeLellis; Arthur S. Tischler
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

3.  Von Hippel-Lindau's Disease, syringomyelia and multiple endocrine tumors: a complex neuroendocrinopathy.

Authors:  A Probst; M Lotz; P Heitz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-06-15

Review 4.  Differential diagnosis of pheochromocytomas and paragangliomas.

Authors:  A M McNichol
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Prevalence of C-cell hyperplasia and medullary thyroid carcinoma in a consecutive series of pheochromocytoma patients.

Authors:  S Jansson; G Hansson; H Salander; G Stenström; L E Tisell
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

6.  [Modern methods in localization of pheochromocytomas (author's transl)].

Authors:  U Cordes; B Braun; M Georgi; F Kümmerle; V Lenner; E Magin; T Philipp; J Beyer
Journal:  Klin Wochenschr       Date:  1979-11-15

7.  The parathyroid glands in multiple endocrine neoplasia type 2b.

Authors:  J A Carney; S I Roth; H Heath; G W Sizemore; A B Hayles
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

8.  Alterations in plasma norepinephrine concentration during surgical resection of pheochromocytoma.

Authors:  J M Feldman; J A Blalock; L Fagraeus; J N Miller; R E Farrell; S A Wells
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

Review 9.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

10.  Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.

Authors:  T C Lairmore; D W Ball; S B Baylin; S A Wells
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.